每一家新店的落地，皆是稳健增长的生动注脚，我们以扎实的脚步，持续印证品牌力量，与远见者并 肩，共拓未来新程。 为何此时是携手共进的契机？ 拓展稳步，布局清晰：发展20+年，丝域在全国多城相继迎来新店开业，这既是市场对专业养发服务的 认可，也是持续把握健康消费趋势、稳步推进城市布局的扎实足迹。 体系完善，支持全程：丝域已布局200+城市，开设门店逾2500家。从选址评估、装修指导，到技术培 训、运营陪跑，我们为合作伙伴提供系统化的支持，助力门店稳健启动与持续经营。 养发创富赛道加速布局 专业，是丝域养发屹立的基石；体系化实力，是我们开拓的底气 这个11月，20+家新店同期绽放深圳、北京、重庆、无锡、上海、成都……燃动全19城 赛道稳健，深耕不辍：丝域以多元化服务为支撑，深耕头皮健康领域，坚持以专业科技驱动服务持续升 级，致力于构建可持续、可复制的成熟服务模型。 【部分门店多图直击 开业盛况】 一起来感受现场的火热与美好吧！ 门店：成都东安天街店 地址：四川省成都市龙湖东安天街 门店：昆明安宁金沙店 地址：安宁市珍泉路金沙小区 门店：icc环贸中心店 地址：雁塔区丈八四路地铁站ICC环贸天地 丝域养发致力于 成为 ...

Summary of Yonghe Medical Conference Call Company Overview - Yonghe Medical is a leading player in the hair transplant industry, performing approximately 4,000 surgeries annually with revenue around 100 million RMB [2][3] - The average price per hair transplant is about 20,000 RMB, while hair care services average around 12,000 RMB, with hair transplant revenue accounting for approximately 80% of total revenue [2][3] Financial Performance - In 2024, Yonghe Medical's total revenue is projected to exceed 1.7 billion RMB, but the company is expected to incur a loss of 200 million RMB due to store opening investments [2][4] - Operating cash flow has turned positive, reaching over 200 million RMB, indicating the company's self-sustaining capability [2][4] - Profitability is anticipated to improve, with expected earnings of several million RMB in 2025 and a potential recovery to around 150 million RMB in 2026 [2][4] Competitive Advantages - Yonghe Medical has enhanced its market share through stable operations, outperforming competitors such as Dama, Xinxing, and Bilian Sheng, who have faced increased operational burdens due to heavy advertising and expansion [2][5][6] - The company holds a 30% stake in CPE Fund, which is expected to boost transaction volume and value extraction [2][6] Valuation Potential - Currently, Yonghe Medical's market capitalization is approximately 1.5 billion RMB, indicating it is undervalued [2][7] - Based on first-tier market chain company valuation standards (10x EBITDA or 1.5x PS), a reasonable valuation is estimated to be around 3 billion RMB [2][7] - If profits recover to 150 million RMB in 2026, the market capitalization could also reach 3 billion RMB based on a 20x price-to-earnings ratio [2][7] Investor Interest - Recent market activity shows a significant increase in investor interest, with daily trading volume rising from hundreds of thousands to a peak of 10 million, indicating heightened attention towards Yonghe Medical [2][8] - The East Wu Securities team has successfully identified other valuable stocks and aims to continue discovering companies with untapped potential [2][8]